Return to results
Journal articles (2018), Journal of Medical Economics, 22 (4), pp. 289-296

Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients

GOODALL G., LAMOTTE M., RAMOS Sofia , MAUNOURY F., PEJCHALOVA B., DE POUVOURVILLE Gérard

Transcatheter aortic valve implantation (TAVI) has become the therapy of choice for treating severe aortic stenosis in patients at high-risk for surgery or where it is considered too risky to attempt. We sought to evaluate the potential cost and clinical impact of TAVI in intermediate risk patients from a French collective perspective. Link to the article

GOODALL, G., LAMOTTE, M., RAMOS, S., MAUNOURY, F., PEJCHALOVA, B. and DE POUVOURVILLE, G. (2018). Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients. Journal of Medical Economics, 22(4), pp. 289-296.

Keywords : #Cost, #effectiveness, #I10, #I39, #SAPIEN-3, #TAVI, #severe-aortic-stenosis, #transcatheter-aortic-valve